Relative preservation of thalamic centromedian nucleus in Parkinsonian patients with dystonia

Movement Disorders

Volumn 24, Issue 14, 2009, Pages 2128-2135

  Truong, Linda ^a,b   Brooks, Daniel ^a   Amaral, Fabricio ^a   Henderson, Jasmine M ^b   Halliday, Glenda M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Centromedian parafascicular nuclei; Dystonia; Falls; Parkinson's disease; Thalamus

Indexed keywords

AGED; ARTICLE; BASAL GANGLION; BRAIN DISEASE; BRAIN FUNCTION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSTONIA; FALLING; HUMAN; HUMAN CELL; HUMAN TISSUE; MOTOR CORTEX; NERVE DEGENERATION; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; THALAMUS MEDIALIS CENTRALIS NUCLEUS; THALAMUS PARAFASCICULAR NUCLEUS;

AGED; ALPHA-SYNUCLEIN; ANTIPARKINSON AGENTS; ATROPHY; CELL COUNT; DISEASE PROGRESSION; DYSTONIA; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; INTRALAMINAR THALAMIC NUCLEI; LEWY BODIES; MALE; MIDDLE AGED; NERVE DEGENERATION; PARKINSON DISEASE;

EID: 70450164047     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22747     Document Type: Article

References (36)

1. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann NY Acad Sci 2003;991:1-14. (Pubitemid 36793796)
2. Greffard S, Verny M, Bonnet AM, et al. Motor score of the Uni- fied Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol 2006;63:584-588.
3. Henderson JM, Carpenter K, Cartwright H, Halliday GM. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Brain 2000;123(Pt 7):1410-1421. (Pubitemid 30420941)
4. Henderson JM, Carpenter K, Cartwright H, Halliday GM. Degeneration of the centre median-parafascicular complex in Parkinson's disease. Ann Neurol 2000;47:345-352. (Pubitemid 30141844)
5. Henderson JM, Schleimer SB, Allbutt H, et al. Behavioural effects of parafascicular thalamic lesions in an animal model of parkinsonism. Behav Brain Res 2005;162:222-232. (Pubitemid 40828534)
6. Matsumoto N, Minamimoto T, Graybiel AM, Kimura M. Neurons in the thalamic CM-Pf complex supply striatal neurons with information about behaviorally significant sensory events. J Neurophysiol 2001;85:960-976. (Pubitemid 32147793)
7. Deleu D, Lagopoulos M, Louon A. Thalamic hand dystonia: an MRI anatomoclinical study. Acta Neurol Belg 2000;100:237-241. (Pubitemid 33601096)
8. Nagaratnam N, Leung H, Bou-Haider P. Lacunar thalamic stroke proclivity for falls. Int J Clin Pract 2004;58:83-85. (Pubitemid 38263239)
9. Delmaire C, Vidailhet M, Elbaz A, et al. Structural abnormalities in the cerebellum and sensorimotor circuit in writer's cramp. Neurology 2007;69:376-380. (Pubitemid 47205665)
10. Obermann M, Yaldizli O, De Greiff A, et al. Morphometric changes of sensorimotor structures in focal dystonia. Mov Disord 2007;22:1117-1123. (Pubitemid 47067221)
11. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211. (Pubitemid 36007810)
12. Geyer HL, Bressman SB. The diagnosis of dystonia. Lancet Neurol 2006;5:780-790.
13. Tolosa E, Compta Y. Dystonia in Parkinson's disease. J Neurol 2006;253(Suppl 7):VII7-VII13.
14. Cavalieri B. Geometria indivisiblibus continuourum. Typis clementis ferronij, bononiae. Reprinted 1966 as geometria degli indivisbili. Torinese, Torino: Unione Tipografico-Editrice; 1635.
15. Harding AJ, Halliday GM, Cullen K. Practical considerations for the use of the optical disector in estimating neuronal number. J Neurosci Methods 1994;51:83-89. (Pubitemid 24089275)
16. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
17. Hirai T, Jones EG. A new parcellation of the human thalamus on the basis of histochemical staining. Brain Res Brain Res Rev 1989;14:1-34. (Pubitemid 19071339)
18. Munkle MC, Waldvogel HJ, Faull RL. Calcium-binding protein immunoreactivity delineates the intralaminar nuclei of the thalamus in the human brain. Neuroscience 1999;90:485-491.
19. Munkle MC, Waldvogel HJ, Faull RL. The distribution of calbindin, calretinin and parvalbumin immunoreactivity in the human thalamus. J Chem Neuroanat 2000;19:155-173.
20. Freyaldenhoven TE, Ali SF, Schmued LC. Systemic administration of MPTP induces thalamic neuronal degeneration in mice. Brain Res 1997;759:9-17.
21. Aymerich MS, Barroso-Chinea P, Perez-Manso M, et al. Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats. Eur J Neurosci 2006;23:2099-2108.
22. Bacci JJ, Kerkerian-Le Goff L, Salin P. Effects of intralaminar thalamic nuclei lesion on glutamic acid decarboxylase (GAD65 and GAD67) and cytochrome oxidase subunit I mRNA expression in the basal ganglia of the rat. Eur J Neurosci 2002;15:1918-1928. (Pubitemid 35471882)
23. Hammond C, Bergman H, Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci 2007;30:357-364. (Pubitemid 46994777)
24. van Eimeren T, Siebner HR. An update on functional neuroimaging of parkinsonism and dystonia. Curr Opin Neurol 2006;19:412-419.
25. Boonstra TA, van der Kooij H, Munneke M, Bloem BR. Gait disorders and balance disturbances in Parkinson's disease: clinical update and pathophysiology. Curr Opin Neurol 2008;21:461-471.
26. Grimbergen YA, Munneke M, Bloem BR. Falls in Parkinson's disease. Curr Opin Neurol 2004;17:405-415.
27. Allcock LM, Rowan EN, Steen IN, Wesnes K, Kenny RA, Burn DJ. Impaired attention predicts falling in Parkinson's disease. Parkinsonism Relat Disord 2009;15:110-115.
28. Kimura M, Minamimoto T, Matsumoto N, Hori Y. Monitoring and switching of cortico-basal ganglia loop functions by the thalamo- striatal system. Neurosci Res 2004;48:355-360. (Pubitemid 38369332)
29. Smith Y, Raju DV, Pare JF, Sidibe M. The thalamostriatal system: a highly specific network of the basal ganglia circuitry. Trends Neurosci 2004;27:520-527. (Pubitemid 39149820)
30. Van der Werf YD, Witter MP, Groenewegen HJ. The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res Brain Res Rev 2002;39:107-140.
31. Horie C, Suzuki Y, Kiyosawa M, et al. Decreased dopamine D(2) receptor binding in essential blepharospasm. Acta Neurol Scand 2009;119:49-54.
32. Suzuki Y, Mizoguchi S, Kiyosawa M, et al. Glucose hypermetabolism in the thalamus of patients with essential blepharospasm. J Neurol 2007;254:890-896. (Pubitemid 47222310)
33. Parent M, Parent A. Single-axon tracing and three-dimensional reconstruction of centre median-parafascicular thalamic neurons in primates. J Comp Neurol 2005;481:127-144. (Pubitemid 39578775)
34. Tang JK, Moro E, Mahant N, et al. Neuronal firing rates and patterns in the globus pallidus internus of patients with cervical dystonia differ from those with Parkinson's disease. J Neurophysiol 2007;98:720-729. (Pubitemid 47236027)
35. Thannickal TC, Lai YY, Siegel JM. Hypocretin (orexin) cell loss in Parkinson's disease. Brain 2007;130(Pt 6):1586-1595. (Pubitemid 47355933)
36. Rinne JO, Ma SY, Lee MS, Collan Y, Roytta M. Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients. Parkinsonism Relat Disord 2008;14:553-557.